Global Solid-Phase Peptide Synthesis (SPPS) Service Market Research Report 2024

Publication ID:

PB502243343

Publication Date:

March 6, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Solid phase peptide synthesis (SPPS) is a technique for peptide synthesis. It can be defined as a process in which a peptide anchored by its c-terminus to an insoluble polymer is assembled by the successive addition of the protected amino acids constituting its sequence.
The global Solid-Phase Peptide Synthesis (SPPS) Service market was valued at US$ 153 million in 2023 and is anticipated to reach US$ 204.7 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
North American market for Solid-Phase Peptide Synthesis (SPPS) Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Solid-Phase Peptide Synthesis (SPPS) Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Solid-Phase Peptide Synthesis (SPPS) Service in Commercial is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Solid-Phase Peptide Synthesis (SPPS) Service include Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, Thermofischer, Bio Basic, JPT and Genscript, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Solid-Phase Peptide Synthesis (SPPS) Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Solid-Phase Peptide Synthesis (SPPS) Service.
Report Scope
The Solid-Phase Peptide Synthesis (SPPS) Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Solid-Phase Peptide Synthesis (SPPS) Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Solid-Phase Peptide Synthesis (SPPS) Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bachem
PolyPeptide
CordenPharma
AmbioPharm
USV Peptides
Thermofischer
Bio Basic
JPT
Genscript
Xinbang Pharma
ScinoPharm
SN Biopharm
CBL
Piramal Pharma
CPC Scientific
AnaSpec
Segment by Type
GMP Services
Non-GMP Services
Segment by Application
Commercial
Scientific Research
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Solid-Phase Peptide Synthesis (SPPS) Service companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Solid-Phase Peptide Synthesis (SPPS) Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 GMP Services
1.2.3 Non-GMP Services
1.3 Market by Application
1.3.1 Global Solid-Phase Peptide Synthesis (SPPS) Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Commercial
1.3.3 Scientific Research
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Solid-Phase Peptide Synthesis (SPPS) Service Market Perspective (2019-2030)
2.2 Solid-Phase Peptide Synthesis (SPPS) Service Growth Trends by Region
2.2.1 Global Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Solid-Phase Peptide Synthesis (SPPS) Service Historic Market Size by Region (2019-2024)
2.2.3 Solid-Phase Peptide Synthesis (SPPS) Service Forecasted Market Size by Region (2025-2030)
2.3 Solid-Phase Peptide Synthesis (SPPS) Service Market Dynamics
2.3.1 Solid-Phase Peptide Synthesis (SPPS) Service Industry Trends
2.3.2 Solid-Phase Peptide Synthesis (SPPS) Service Market Drivers
2.3.3 Solid-Phase Peptide Synthesis (SPPS) Service Market Challenges
2.3.4 Solid-Phase Peptide Synthesis (SPPS) Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Solid-Phase Peptide Synthesis (SPPS) Service Players by Revenue
3.1.1 Global Top Solid-Phase Peptide Synthesis (SPPS) Service Players by Revenue (2019-2024)
3.1.2 Global Solid-Phase Peptide Synthesis (SPPS) Service Revenue Market Share by Players (2019-2024)
3.2 Global Solid-Phase Peptide Synthesis (SPPS) Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Solid-Phase Peptide Synthesis (SPPS) Service Revenue
3.4 Global Solid-Phase Peptide Synthesis (SPPS) Service Market Concentration Ratio
3.4.1 Global Solid-Phase Peptide Synthesis (SPPS) Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Solid-Phase Peptide Synthesis (SPPS) Service Revenue in 2023
3.5 Solid-Phase Peptide Synthesis (SPPS) Service Key Players Head office and Area Served
3.6 Key Players Solid-Phase Peptide Synthesis (SPPS) Service Product Solution and Service
3.7 Date of Enter into Solid-Phase Peptide Synthesis (SPPS) Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Solid-Phase Peptide Synthesis (SPPS) Service Breakdown Data by Type
4.1 Global Solid-Phase Peptide Synthesis (SPPS) Service Historic Market Size by Type (2019-2024)
4.2 Global Solid-Phase Peptide Synthesis (SPPS) Service Forecasted Market Size by Type (2025-2030)
5 Solid-Phase Peptide Synthesis (SPPS) Service Breakdown Data by Application
5.1 Global Solid-Phase Peptide Synthesis (SPPS) Service Historic Market Size by Application (2019-2024)
5.2 Global Solid-Phase Peptide Synthesis (SPPS) Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Solid-Phase Peptide Synthesis (SPPS) Service Market Size (2019-2030)
6.2 North America Solid-Phase Peptide Synthesis (SPPS) Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Country (2019-2024)
6.4 North America Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Solid-Phase Peptide Synthesis (SPPS) Service Market Size (2019-2030)
7.2 Europe Solid-Phase Peptide Synthesis (SPPS) Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Country (2019-2024)
7.4 Europe Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Solid-Phase Peptide Synthesis (SPPS) Service Market Size (2019-2030)
8.2 Asia-Pacific Solid-Phase Peptide Synthesis (SPPS) Service Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Solid-Phase Peptide Synthesis (SPPS) Service Market Size (2019-2030)
9.2 Latin America Solid-Phase Peptide Synthesis (SPPS) Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Country (2019-2024)
9.4 Latin America Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Solid-Phase Peptide Synthesis (SPPS) Service Market Size (2019-2030)
10.2 Middle East & Africa Solid-Phase Peptide Synthesis (SPPS) Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bachem
11.1.1 Bachem Company Detail
11.1.2 Bachem Business Overview
11.1.3 Bachem Solid-Phase Peptide Synthesis (SPPS) Service Introduction
11.1.4 Bachem Revenue in Solid-Phase Peptide Synthesis (SPPS) Service Business (2019-2024)
11.1.5 Bachem Recent Development
11.2 PolyPeptide
11.2.1 PolyPeptide Company Detail
11.2.2 PolyPeptide Business Overview
11.2.3 PolyPeptide Solid-Phase Peptide Synthesis (SPPS) Service Introduction
11.2.4 PolyPeptide Revenue in Solid-Phase Peptide Synthesis (SPPS) Service Business (2019-2024)
11.2.5 PolyPeptide Recent Development
11.3 CordenPharma
11.3.1 CordenPharma Company Detail
11.3.2 CordenPharma Business Overview
11.3.3 CordenPharma Solid-Phase Peptide Synthesis (SPPS) Service Introduction
11.3.4 CordenPharma Revenue in Solid-Phase Peptide Synthesis (SPPS) Service Business (2019-2024)
11.3.5 CordenPharma Recent Development
11.4 AmbioPharm
11.4.1 AmbioPharm Company Detail
11.4.2 AmbioPharm Business Overview
11.4.3 AmbioPharm Solid-Phase Peptide Synthesis (SPPS) Service Introduction
11.4.4 AmbioPharm Revenue in Solid-Phase Peptide Synthesis (SPPS) Service Business (2019-2024)
11.4.5 AmbioPharm Recent Development
11.5 USV Peptides
11.5.1 USV Peptides Company Detail
11.5.2 USV Peptides Business Overview
11.5.3 USV Peptides Solid-Phase Peptide Synthesis (SPPS) Service Introduction
11.5.4 USV Peptides Revenue in Solid-Phase Peptide Synthesis (SPPS) Service Business (2019-2024)
11.5.5 USV Peptides Recent Development
11.6 Thermofischer
11.6.1 Thermofischer Company Detail
11.6.2 Thermofischer Business Overview
11.6.3 Thermofischer Solid-Phase Peptide Synthesis (SPPS) Service Introduction
11.6.4 Thermofischer Revenue in Solid-Phase Peptide Synthesis (SPPS) Service Business (2019-2024)
11.6.5 Thermofischer Recent Development
11.7 Bio Basic
11.7.1 Bio Basic Company Detail
11.7.2 Bio Basic Business Overview
11.7.3 Bio Basic Solid-Phase Peptide Synthesis (SPPS) Service Introduction
11.7.4 Bio Basic Revenue in Solid-Phase Peptide Synthesis (SPPS) Service Business (2019-2024)
11.7.5 Bio Basic Recent Development
11.8 JPT
11.8.1 JPT Company Detail
11.8.2 JPT Business Overview
11.8.3 JPT Solid-Phase Peptide Synthesis (SPPS) Service Introduction
11.8.4 JPT Revenue in Solid-Phase Peptide Synthesis (SPPS) Service Business (2019-2024)
11.8.5 JPT Recent Development
11.9 Genscript
11.9.1 Genscript Company Detail
11.9.2 Genscript Business Overview
11.9.3 Genscript Solid-Phase Peptide Synthesis (SPPS) Service Introduction
11.9.4 Genscript Revenue in Solid-Phase Peptide Synthesis (SPPS) Service Business (2019-2024)
11.9.5 Genscript Recent Development
11.10 Xinbang Pharma
11.10.1 Xinbang Pharma Company Detail
11.10.2 Xinbang Pharma Business Overview
11.10.3 Xinbang Pharma Solid-Phase Peptide Synthesis (SPPS) Service Introduction
11.10.4 Xinbang Pharma Revenue in Solid-Phase Peptide Synthesis (SPPS) Service Business (2019-2024)
11.10.5 Xinbang Pharma Recent Development
11.11 ScinoPharm
11.11.1 ScinoPharm Company Detail
11.11.2 ScinoPharm Business Overview
11.11.3 ScinoPharm Solid-Phase Peptide Synthesis (SPPS) Service Introduction
11.11.4 ScinoPharm Revenue in Solid-Phase Peptide Synthesis (SPPS) Service Business (2019-2024)
11.11.5 ScinoPharm Recent Development
11.12 SN Biopharm
11.12.1 SN Biopharm Company Detail
11.12.2 SN Biopharm Business Overview
11.12.3 SN Biopharm Solid-Phase Peptide Synthesis (SPPS) Service Introduction
11.12.4 SN Biopharm Revenue in Solid-Phase Peptide Synthesis (SPPS) Service Business (2019-2024)
11.12.5 SN Biopharm Recent Development
11.13 CBL
11.13.1 CBL Company Detail
11.13.2 CBL Business Overview
11.13.3 CBL Solid-Phase Peptide Synthesis (SPPS) Service Introduction
11.13.4 CBL Revenue in Solid-Phase Peptide Synthesis (SPPS) Service Business (2019-2024)
11.13.5 CBL Recent Development
11.14 Piramal Pharma
11.14.1 Piramal Pharma Company Detail
11.14.2 Piramal Pharma Business Overview
11.14.3 Piramal Pharma Solid-Phase Peptide Synthesis (SPPS) Service Introduction
11.14.4 Piramal Pharma Revenue in Solid-Phase Peptide Synthesis (SPPS) Service Business (2019-2024)
11.14.5 Piramal Pharma Recent Development
11.15 CPC Scientific
11.15.1 CPC Scientific Company Detail
11.15.2 CPC Scientific Business Overview
11.15.3 CPC Scientific Solid-Phase Peptide Synthesis (SPPS) Service Introduction
11.15.4 CPC Scientific Revenue in Solid-Phase Peptide Synthesis (SPPS) Service Business (2019-2024)
11.15.5 CPC Scientific Recent Development
11.16 AnaSpec
11.16.1 AnaSpec Company Detail
11.16.2 AnaSpec Business Overview
11.16.3 AnaSpec Solid-Phase Peptide Synthesis (SPPS) Service Introduction
11.16.4 AnaSpec Revenue in Solid-Phase Peptide Synthesis (SPPS) Service Business (2019-2024)
11.16.5 AnaSpec Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Bachem
PolyPeptide
CordenPharma
AmbioPharm
USV Peptides
Thermofischer
Bio Basic
JPT
Genscript
Xinbang Pharma
ScinoPharm
SN Biopharm
CBL
Piramal Pharma
CPC Scientific
AnaSpec

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂